NCT03175562View on ClinicalTrials.gov

To Assess the Cutaneous Irritation and Sensitization Potential of a Cosmetic Facial Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Participants

NACompletedINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

March 27, 2017

Primary Completion Date

May 19, 2017

Study Completion Date

May 19, 2017

Conditions
Skin Care
Interventions
OTHER

Facial micellar cleanser

Participant will have each product applied topically via semi occlusive patch, on site by the technician. Each patch will remain in place for 48 (± 2) hours on weekdays and 72 (± 2) hours on weekends.

OTHER

Saline Solution: Sodium Chloride (NaCl; 0.9%)

Participant will have each product applied topically via semi occlusive patch, on site by the technician. Each patch will remain in place for 48 (± 2) hours on weekdays and 72 (± 2) hours on weekends.

Trial Locations (1)

13271-130

GSK Investigational Site, Valinhos

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT03175562 - To Assess the Cutaneous Irritation and Sensitization Potential of a Cosmetic Facial Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Participants | Biotech Hunter | Biotech Hunter